1. Home
  2. NBTX vs DFDV Comparison

NBTX vs DFDV Comparison

Compare NBTX & DFDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • DFDV
  • Stock Information
  • Founded
  • NBTX 2003
  • DFDV 2018
  • Country
  • NBTX France
  • DFDV United States
  • Employees
  • NBTX N/A
  • DFDV N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • DFDV Finance: Consumer Services
  • Sector
  • NBTX Health Care
  • DFDV Finance
  • Exchange
  • NBTX Nasdaq
  • DFDV Nasdaq
  • Market Cap
  • NBTX 167.8M
  • DFDV 143.9M
  • IPO Year
  • NBTX 2020
  • DFDV N/A
  • Fundamental
  • Price
  • NBTX $4.10
  • DFDV $17.51
  • Analyst Decision
  • NBTX Strong Buy
  • DFDV
  • Analyst Count
  • NBTX 1
  • DFDV 0
  • Target Price
  • NBTX $8.00
  • DFDV N/A
  • AVG Volume (30 Days)
  • NBTX 11.5K
  • DFDV 2.1M
  • Earning Date
  • NBTX 04-02-2025
  • DFDV 05-14-2025
  • Dividend Yield
  • NBTX N/A
  • DFDV N/A
  • EPS Growth
  • NBTX N/A
  • DFDV N/A
  • EPS
  • NBTX N/A
  • DFDV N/A
  • Revenue
  • NBTX N/A
  • DFDV $1,975,695.00
  • Revenue This Year
  • NBTX N/A
  • DFDV N/A
  • Revenue Next Year
  • NBTX $221.06
  • DFDV N/A
  • P/E Ratio
  • NBTX N/A
  • DFDV N/A
  • Revenue Growth
  • NBTX N/A
  • DFDV 1.47
  • 52 Week Low
  • NBTX $2.76
  • DFDV $0.48
  • 52 Week High
  • NBTX $7.29
  • DFDV $53.88
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 64.63
  • DFDV N/A
  • Support Level
  • NBTX $3.64
  • DFDV N/A
  • Resistance Level
  • NBTX $4.20
  • DFDV N/A
  • Average True Range (ATR)
  • NBTX 0.16
  • DFDV 0.00
  • MACD
  • NBTX 0.04
  • DFDV 0.00
  • Stochastic Oscillator
  • NBTX 88.51
  • DFDV 0.00

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About DFDV DeFi Development Corp. Common Stock

DeFi Development Corp is an AI-powered online platform that connects the commercial real estate industry by providing data and software subscriptions as well as value-add services to multifamily and commercial property professionals.

Share on Social Networks: